Pfizer Picks Up EU Pegfilgrastim Approval

Commission Offers Formal Nod For Nyvepria Version Following US Approval

 
• By Dave Wallace

Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.

EU boxing gloves
Multiple biosimilar versions of pegfilgrastim are duking it out in Europe • Source: Shutterstock

More from Products

More from Generics Bulletin